These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24188875)

  • 1. Decreased inhibin B responses following recombinant human chorionic gonadotropin administration in normal women and women with polycystic ovary syndrome.
    Shayya RF; Rosencrantz MA; Chuan SS; Cook-Andersen H; Roudebush WE; Irene Su H; Shimasaki S; Chang RJ
    Fertil Steril; 2014 Jan; 101(1):275-9. PubMed ID: 24188875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
    Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between 17-hydroxyprogesterone responses to human chorionic gonadotropin and markers of ovarian follicle morphology in women with polycystic ovary syndrome.
    Maas KH; Chuan SS; Cook-Andersen H; Su HI; Duleba A; Chang RJ
    J Clin Endocrinol Metab; 2015 Jan; 100(1):293-300. PubMed ID: 25313914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Serum anti-Mullerian hormone responses after recombinant human chorionic gonadotropin stimulation in women with polycystic ovary syndrome.
    Cook-Andersen H; Chuan SS; Maas K; Rosencrantz MA; Su HI; Lawson M; Mason HD; Chang RJ
    J Clin Endocrinol Metab; 2015 Jan; 100(1):251-7. PubMed ID: 25303490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone.
    Welt CK; Taylor AE; Martin KA; Hall JE
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5559-65. PubMed ID: 12466353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome.
    Wachs DS; Coffler MS; Malcom PJ; Shimasaki S; Chang RJ
    J Clin Endocrinol Metab; 2008 May; 93(5):1827-33. PubMed ID: 18285408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism.
    Pigny P; Cortet-Rudelli C; Decanter C; Deroubaix D; Soudan B; Duhamel A; Dewailly D
    Fertil Steril; 2000 May; 73(5):972-7. PubMed ID: 10785223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evidence for predominance of delta-5 steroid production in women with polycystic ovary syndrome.
    Rosencrantz MA; Coffler MS; Haggan A; Duke KB; Donohue MC; Shayya RF; Su HI; Chang RJ
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1106-13. PubMed ID: 21270326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome.
    Cortet-Rudelli C; Pigny P; Decanter C; Leroy M; Maunoury-Lefebvre C; Thomas-Desrousseaux P; Dewailly D
    Fertil Steril; 2002 Feb; 77(2):281-7. PubMed ID: 11821084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome.
    Maas KH; Chuan S; Harrison E; Cook-Andersen H; Duleba AJ; Chang RJ
    Fertil Steril; 2016 Oct; 106(5):1252-1257. PubMed ID: 27473350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of functionally typical and atypical types of polycystic ovary syndrome.
    Hirshfeld-Cytron J; Barnes RB; Ehrmann DA; Caruso A; Mortensen MM; Rosenfield RL
    J Clin Endocrinol Metab; 2009 May; 94(5):1587-94. PubMed ID: 19240152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B.
    Chu MC; Carmina E; Wang J; Lobo RA
    Fertil Steril; 2005 Dec; 84(6):1685-8. PubMed ID: 16359965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
    Yetim A; Yetim Ç; Baş F; Erol OB; Çığ G; Uçar A; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):288-97. PubMed ID: 27125339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of inhibin B and estradiol responses to intravenous FSH in women with polycystic ovary syndrome and normal women.
    Rosencrantz MA; Wachs DS; Coffler MS; Malcom PJ; Donohue M; Chang RJ
    Hum Reprod; 2010 Jan; 25(1):198-203. PubMed ID: 19850592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.
    Anderson RA; Groome NP; Baird DT
    Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of follicle-stimulating-hormone-stimulated dimeric inhibin and estradiol responses as indicators of granulosa cell function in polycystic ovary syndrome and normal women.
    Wachs DS; Coffler MS; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2920-5. PubMed ID: 16720653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of estradiol on granulosa cell responses to FSH in women with polycystic ovary syndrome.
    Homer MV; Rosencrantz MA; Shayya RF; Chang RJ
    Reprod Biol Endocrinol; 2017 Feb; 15(1):13. PubMed ID: 28187771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17-Hydroxyprogesterone responses to human chorionic gonadotropin are not associated with serum anti-Mullerian hormone levels among adolescent girls with polycystic ovary syndrome.
    Hou J; Cook-Andersen H; Su HI; Shayya R; Maas KH; Burt-Solorzano CM; Kumar A; Chang RJ
    J Pediatr Endocrinol Metab; 2016 Jul; 29(7):835-40. PubMed ID: 27166718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone.
    Dafopoulos K; Venetis C; Messini CI; Pournaras S; Anifandis G; Garas A; Messinis IE
    Reprod Biol Endocrinol; 2011 Apr; 9():59. PubMed ID: 21529351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.